Document Detail


Severe pulmonary hypertension: data from the Swiss Registry.
MedLine Citation:
PMID:  11486567     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Severe pulmonary hypertension (PH) is a rare disease with a dismal prognosis if untreated. Progress in diagnosis and in the development of effective therapeutic options has created new interest in this pathology. There are, however, only limited data on the prevalence of severe PH unrelated to chronic left ventricular failure or COPD, on the associated conditions and on the parameters with a prognostic impact. With the aid of a retrospective registry we have collected data from 5 centres in Switzerland and attempted to answer the above questions.
METHODS: Data on patients with PH from 4 university facilities (Zurich, Basle, Geneva and Lausanne) and one well-defined geographical area (Ticino) were retrospectively collected and analysed up to December 1999. Clinical and haemodynamic parameters and associated diseases were noted. We were also interested in the age distribution of the patients and the year of diagnosis of PH.
RESULTS: We found 106 patients with severe PH (43 men, 63 women, median age 43 years); 79% were in NYHA class III or IV. There was a steep rise in diagnosis of PH after 1995. In 74% PH was either primary or associated with collagen vascular disease or thromboembolic disease. By the end of the observation period 30% of the patients had died. The best distinguishing parameters between surviving patients and those who eventually died were the 6-minute walking test (363 vs. 235 metres, p = 0.002), the NYHA class (II vs III/IV, p = 0.015), and mixed venous saturation (66.5 vs. 57.9%, p = 0.006). Therapy consisted of calcium antagonists in 18% and of (inhaled) prostanoids, chiefly iloprost, in 33%. Seven patients underwent lung transplantation.
CONCLUSIONS: We conclude that PH is diagnosed more often as diagnostic and therapeutic options improve; that primary forms, and those associated with collagen vascular disease and with chronic venous thromboembolism, make up three-quarters of the aetiologies; and that the 6-minute walking test, the functional class and mixed venous saturation are the best prognostic parameters.
Authors:
H Stricker; G Domenighetti; W Popov; R Speich; L Nicod; J D Aubert; M Solèr;
Related Documents :
11449097 - Chronic middle ear disease and gastroesophageal reflux disease: a causal relation?
12562447 - Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (...
15242497 - Autonomic responses to heartburn induced by esophageal acid infusion.
18491737 - Reflux in cystoplasties.
15046467 - Refinement and validation of a french in-patient experience questionnaire.
14763077 - Outcome in children on chronic peritoneal dialysis.
Publication Detail:
Type:  Journal Article; Multicenter Study    
Journal Detail:
Title:  Swiss medical weekly     Volume:  131     ISSN:  1424-7860     ISO Abbreviation:  Swiss Med Wkly     Publication Date:  2001 Jun 
Date Detail:
Created Date:  2001-08-06     Completed Date:  2001-12-07     Revised Date:  2011-02-15    
Medline Journal Info:
Nlm Unique ID:  100970884     Medline TA:  Swiss Med Wkly     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  346-50     Citation Subset:  IM    
Affiliation:
Internal Medicine of Regional Hospital, Locarno. hans.stricker@eoc.ch
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Age Distribution
Aged
Blood Pressure / physiology
Child
Exercise Test
Female
Humans
Hypertension, Pulmonary / diagnosis*,  physiopathology*,  therapy
Male
Middle Aged
Prognosis
Pulmonary Wedge Pressure / physiology
Registries*
Retrospective Studies
Survival Analysis
Switzerland
Vascular Resistance / physiology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment of primary and secondary liver malignancy.
Next Document:  Sympathetic stimulation using the cold pressor test increases coronary collateral flow.